Artificial Intelligence in Diagnostics Market - Top Companies and Manufacturers

Companies Dominating the Artificial Intelligence in Diagnostics Landscape

The competition level in the artificial intelligence in diagnostics market is very intense, and it covers several key players who contribute to raising innovation and commercialization for diagnostic tools based on Artificial Intelligence. Key companies include Google, Siemens Healthineers, Bayer, and GE HealthCare, among many others. These firms are effectively utilizing various AI technologies to create diagnostic solutions that are highly efficient and vastly accurate. Moreover, these companies are into product development, partnerships, and mergers and acquisitions to maintain their positions within the market. Here are some leading players in the artificial intelligence in diagnostics market:

IBM Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Imagen Technologies
NVIDIA Corporation
PathAI
Aidoc
AliveCor Inc.
Digital Diagnostics, Inc.
Enlitic
RADLogics
Riverain Technologies
Siemens Healthineers
Sophia Genetics
Tempus
Vuno, Inc.
Zebra Medical Vision, Inc.

Browse Key Market Insights with Data Illustration:

Artificial Intelligence in Diagnostics Market Size & Share, Growth Forecasts 2037

In the News

In June 2024, AliveCor secured U.S. FDA clearance for its KAI 12L AI technology and the Kardia 12L ECG System, paving the way for its commercial launch. This cutting-edge technology is set to improve the company's market position, enhancing its sales potential in the near future. The AI-powered system is designed to provide more accurate heart health diagnostics, offering a significant advancement in cardiac care. This approval underscores AliveCor's leadership in AI-driven diagnostic tools.
In May 2023, Metropolis Healthcare Limited introduced a state-of-the-art testing platform using Component Resolved Diagnostics (CRD) to detect allergies in India. This 4th generation technology leverages artificial intelligence to help clinicians make more informed decisions regarding treatment options. The AI integration offers deeper insights, aiding in the optimization of allergy treatment plans. This development marks a significant step forward in allergy diagnostics, enhancing precision and improving patient outcomes.

Frequently Asked Questions (FAQ)

The artificial intelligence in diagnostics market size is USD 1.3 billion in 2024.

The global artificial intelligence in diagnostics market size was valued at US 1.3 billion in 2024 and is anticipated to surpass USD 19.9 billion by the end of 2037, rising at a CAGR of 23.0% over the forecast period, i.e., 2025-2037.

Key players in the market are IBM Corporation, Imagen Technologies, including Aidoc, AliveCor Inc., Digital Diagnostics, Inc., Enlitic, NVIDIA Corporation, PathAI, RADLogics, and Riverain Technologies.

The software segment is expected to hold a dominating share during the forecast period.

North America is anticipated to dominate the industry with a share of 41.5% during the forecast period.

Artificial Intelligence in Diagnostics Market - Top Companies and Manufacturers

Companies Dominating the Artificial Intelligence in Diagnostics Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the artificial intelligence in diagnostics market?

What is the outlook for the artificial intelligence in diagnostics market?

Who are the major key players dominating the artificial intelligence in diagnostics market?

Which component is expected to lead the artificial intelligence in diagnostics market by 2037?

Which region will provide more business opportunities for the growth of the artificial intelligence in diagnostics market in the future?